Kline & Specter had several victories last year in two major products liability/mass tort litigations docketed in the Philadelphia courts. These involved Risperdal, the antipsychotic drug found to be linked to gynecomastia, and vaginal mesh, a product that is surgically implanted to treat organ prolapse and urinary incontinence and that has been alleged to be defective, eroding and causing severe pain in some patients.

In one vaginal mesh case, the firm won a $57.1 million verdict, including $50 million in punitive damages, against defendant Ethicon, a Johnson & Johnson subsidiary. The firm also won a $20 million verdict against Ethicon, which included $17.5 million in punitives.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]